Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Subject recruitment for cancer control studies in an adverse environment.
Histological assessment of fifty breast capsules from smooth and textured augmentation and reconstruction mammoplasty prostheses with emphasis on the role of synovial metaplasia.
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.
Intravenous immunoglobulin: a life-saving (and potentially fatal) treatment.
Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets. Mol Pharmacol. 1983 Sep; 24(2):324-8.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carcinoma 256, Walker
Cells, Cultured
DNA, Neoplasm
Estramustine
HeLa Cells
Humans
Macromolecular Substances
Nitrogen Mustard Compounds
Rats
authors with profiles
Kenneth D. Tew